SecBot SecBot
Insider Cluster (2 insiders) ·Filed Apr 16, 2026

CGTX

COGNITION THERAPEUTICS INC
BULLISH
Impact 5/10
Horizonweeks Processed6mo ago
Insider cluster: 2 insiders, $21K total
Actionable Insight ▲ Bullish

Monitor for follow-up purchases or commentary around upcoming clinical data readouts or financing activities. While the dollar amount is small, the participation of the CEO and CMO adds qualitative weight — a signal worth watching in this micro-cap biotech.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CGTX ▼ -8.11% at T+60d
LONG call ✗ call lost -8.11% · α vs SPY -15.15% · entry $1.11 → $1.02
Entry = T+0 close
Apr 15, 2026
via day close
T+1d
+7.21%
call +7.21% · α +5.99%
$1.19
settled 6mo ago
T+5d
+13.51%
call +13.51% · α +12.53%
$1.26
settled 6mo ago
T+20d
+8.11%
call +8.11% · α +2.29%
$1.20
settled 6mo ago
T+60d
-8.11%
call -8.11% · α -15.15%
$1.02
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Cognition Therapeutics (CGTX) — the CEO and Chief Medical Officer — purchased shares in the open market, spending $10K and $11K respectively. This insider buying, while modest in dollar terms, involves key leadership and may signal confidence amid a small market cap of $106M.

Key Financial Metrics

Direction
buying
Total Value
$21.2K
Insiders
2

Key Facts

  • CEO Lisa Ricciardi purchased 9,175 shares for $10,092.50 at $1.10 per share on April 16, 2026.
  • Chief Medical Officer Anthony Caggiano purchased 10,000 shares for $11,100 at $1.11 per share on April 16, 2026.
  • Total open-market purchases in the cluster amount to $21,192.50 across two C-suite executives.

Financial Impact

$21.2K in open-market buying by two C-suite executives, representing 0.02% of market cap

insider sentimentmarket confidence

Risk Factors

  • The total value of purchases is low ($21K), representing only 0.02% of market cap, limiting material impact.
  • No insider buying from the CFO was included in this specific cluster window, though he made a separate purchase on the same day.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CGTX-1776716219397
11 reports for CGTX
Performance horizon
50% Hit rate @ T+1 2 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +35.20%May 21, 2026
Filters
Rows
Reports for CGTX — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
8-K
BULLISH ★ 7/10
$0.7010 $0.7188▲ +2.54%▲ +3.06%$0.7196 (+2.65%)
Jun 4, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$1.36 $1.29▼ −5.15%▼ −2.55%$0.7196 (−47.09%)
Jun 1, 2026
21w ago
Press Release
NEUTRAL ★ 2/10
$1.25 $1.35▲ +8.00%▲ +7.86%$0.7196 (−42.43%)
May 21, 2026
22w ago
Press Release
BULLISH ★ 6/10
$1.25 $1.26▲ +0.80%▲ +0.35%$0.7196 (−42.43%)
May 14, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$1.20 $1.14▼ −5.00%▼ −3.77%$0.7196 (−40.03%)
May 7, 2026
24w ago
8-K
NEUTRAL ★ 5/10
$1.21 $1.18▼ −2.48%▼ −2.71%$0.7196 (−40.53%)
Apr 16, 2026
27w ago
Insider Cluster
BULLISH ★ 5/10
$1.11 $1.19▲ +7.21%▲ +5.99%$0.7196 (−35.17%)
Mar 26, 2026
30w ago
Press Release
NEUTRAL ★ 5/10
$1.08 $0.7300▼ −32.41%▼ −30.73%$0.7196 (−33.37%)
Mar 23, 2026
31w ago
Press Release
NEUTRAL ★ 3/10
$1.13 $1.10▼ −2.65%▼ −2.30%$0.7196 (−36.32%)
Mar 17, 2026
31w ago
Press Release
BULLISH ★ 8/10
$1.15 $1.10▼ −4.35%▼ −2.95%$0.7196 (−37.43%)
Showing 10 of 11

US Market Status

Market Open — Closes in 5h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026